Economic availability of medicinal products, which affect on structure and mineralization of bones on the pharmaceutical market of Ukraine
Journal Title: Фармацевтичний журнал - Year 2018, Vol 1, Issue 1
Abstract
In recent decades, the problem of osteoporosis has become acute for Ukraine in connection with two demographic processes: a sharp increase in the population of the elderly and senile age and, correspondingly, the number of women in postmenopausal women. At present, the share of the population of Ukraine at the age of 60 years and older is 23.1% (men – 18.1%, women – 27.3%). The number of patients with osteoporosis and its complications is increasing. In connection with this, an analysis of the assortment of medicines affecting the structure and mineralization of bones (bisphosphonates) was carried out. The analysis was conducted during 2014–2016 according to the analytical system of research of the pharmaceutical market «RharmExplorer». For the analysis of socio-economic accessibility of bisphosphonates, an indicator of adequacy of solvency was calculated. In the analysis of the pharmaceutical market in Ukraine the period from 2014 to 2016, 10 INN were installed. In 2014, the market of Ukraine was represented by 41 TN, of which 9 TN of domestic production and 32 TN of foreign production. In 2015, there are 44 TNs, of which 11 TN of domestic production and 33 TN of foreign production. In 2016, there are 40 TNs, of which 12TN of domestic production and 28 TN of foreign production. The obtained data testify that preparations influencing the structure and mineralization of bones are represented on the market in a wide range. During the study period 2014–2016, there were 10 INN drugs on the market, on the basis of which 41, 44 and 40 TNs were represented by years respectively. Analysis of economic accessibility of bisphosphonates showed that the vast majority of them for a course of treatment for 1 month is available for all categories of the population. Only preparations based on zoledronic acid and denzomab are not readily available to the public. In 2016, 100% of alendron acid preparations and 50% of risedron acid preparations were classified as highly available preparations.
Authors and Affiliations
L. V. Iakovlieva, N. A. Matiashova, E. V. Stalna
Keywords
Related Articles
- EP ID EP551743
- DOI 10.32352/0367-3057.1-2.18.01
- Views 60
- Downloads 0
Spectral response аnd electronic structure оf synthetic coumarin derivatives. P a r t IV. Study оf the UV-spectra оf warfarin sodium clathrate
Warfarin is a vitamin K antagonist that was first developed by Wisconsion Alunini Research Foundation in 1947. The use of warfarin in the treatment fоr decrease blood clotting, promotes the emergence of a number of side...
Analysis of combined cream with antifungal activity in terms of «microbiological purity»
According to GMP requirements, quality control of medicinal products justifies their safety and effectiveness from the development and production to the consumer. One of the important parameters in the development of a n...
Analysis of drug group D07 «Corticosteroids for use in dermatology» on the Ukrainian pharmaceutical market
In some cases, ringworm, accompanied by inflammatory reaction of skin treated with combined administration of antifungal drugs and corticosteroids local action. In Ukraine there is an unequal distribution of the producti...
Synthesis and physical-chemical properties of 8-bromo-3-methyl-7-α-methylbenzylxanthine derivatives
The level of modern pharmaceutical science development is determined by the introduction in medical practice of new effective and non-toxic drugs. The problem of new drugs search depends on the presence in the arsenal of...
Analysis of the list of dugs for the treatment of bronchial asthma in children acording to state form
Today, in the conditions of economic instability of the country, provision of rational pharmacotherapy is an important element of the development of the health system of Ukraine. An effective tool for this is the state f...